Shareholders who bought Nano-X Imaging securities between March 31, 2025 and April 17, 2026 are the subject of a federal class action that accuses the company of overstating how well its operations were running.
Rosen Law Firm, which announced the case, says a class action has already been filed against Nano-X Imaging Ltd. (NASDAQ: NNOX). Anyone who wants to serve as lead plaintiff must move the court by August 11, 2026. The firm describes a lead plaintiff as a representative party who directs the litigation for the other class members.
What the lawsuit alleges
According to the complaint, defendants made false or misleading statements during the class period, or failed to disclose key facts. It lists five points.
The company overstated the efficiency gains it said it had achieved, and the rise in demand for its products. In reality, its production and manufacturing operations were poorly matched to that demand. That meant sharply higher operating expenses and cash burn. Those problems made it more likely that Nano-X would have to take disruptive steps on its manufacturing, with significant restructuring and impairment charges. Given all of this, the suit says, the company’s public statements were materially false and misleading throughout.
When the true details reached the market, the lawsuit claims, investors suffered damages.
Status of the case
No class has been certified. Until one is, investors are not represented by counsel unless they retain a lawyer of their choice. They can also remain absent class members and take no action. Rosen says an investor’s ability to share in any future recovery does not depend on serving as lead plaintiff.
The allegations are unproven.
Sources
- NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit
- NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit
